Anatomy Quiz: Blood Types And Abo Rh Compatibility
17 questions · exam conditions
0:00
Blood Types And Abo Rh CompatibilityQuestion 1 of 17

A woman with type AB-negative blood is pregnant with her second child. Her first child was AB-positive. During this current pregnancy, which scenario would most likely require Rh immune globulin (RhoGAM) administration?

Administration is needed immediately because she already has anti-Rh antibodies from her first pregnancy
Administration is unnecessary because AB-negative mothers cannot develop anti-Rh antibodies
Administration should occur at 28 weeks and after delivery if this baby is Rh-positive
Administration is only needed if this baby is AB-negative like the mother
Administration is contraindicated because her AB blood type provides natural immunity
← Back to quizzes

Anatomy Quiz

Anatomy Quiz: Blood Types And Abo Rh Compatibility

Practice Blood Types And Abo Rh Compatibility in Anatomy with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Blood Types And Abo Rh Compatibility, giving you a quick way to practice the rules, question types, and explanations that matter most for Anatomy.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A woman with type AB-negative blood is pregnant with her second child. Her first child was AB-positive. During this current pregnancy, which scenario would most likely require Rh immune globulin (RhoGAM) administration?

  1. Administration is needed immediately because she already has anti-Rh antibodies from her first pregnancy
  2. Administration is unnecessary because AB-negative mothers cannot develop anti-Rh antibodies
  3. Administration should occur at 28 weeks and after delivery if this baby is Rh-positive (correct answer)
  4. Administration is only needed if this baby is AB-negative like the mother
  5. Administration is contraindicated because her AB blood type provides natural immunity
Explanation: When you encounter questions about Rh incompatibility and RhoGAM, focus on the core principle: preventing maternal sensitization to Rh-positive fetal blood cells that could harm future pregnancies. This mother is Rh-negative, and her first child was Rh-positive, meaning she was potentially exposed to Rh antigens during that pregnancy. However, proper RhoGAM administration during and after her first pregnancy would have prevented sensitization. For this current pregnancy, standard protocol calls for RhoGAM at 28 weeks gestation (prophylactic dose) and after delivery if the baby tests Rh-positive. This prevents any sensitization from fetal-maternal blood mixing that commonly occurs during delivery. Option A incorrectly assumes she already has anti-Rh antibodies. If she had received proper RhoGAM during her first pregnancy, she wouldn't be sensitized. Even if she were sensitized, RhoGAM would be ineffective since it prevents sensitization rather than treating existing antibodies. Option B is completely false. Rh-negative individuals can absolutely develop anti-Rh antibodies when exposed to Rh-positive blood—this is the entire basis of Rh incompatibility disease. Option D reverses the logic. RhoGAM is only needed when there's potential exposure to Rh-positive fetal blood. If the baby is Rh-negative like mom, there's no risk of sensitization. Remember: RhoGAM prevents sensitization in Rh-negative mothers carrying potentially Rh-positive babies. The standard timing is 28 weeks and postpartum if baby is Rh-positive, regardless of previous pregnancy outcomes.

Question 2

A laboratory technician observes that a blood sample agglutinates when mixed with anti-A serum but shows no reaction with anti-B or anti-Rh sera. However, when the sample is tested with anti-D serum (a more sensitive Rh test), weak agglutination occurs. How should this blood be classified for transfusion purposes?

  1. Type A-positive, suitable for transfusion to A-positive or AB-positive recipients
  2. Type A-negative, suitable for transfusion to any A or AB recipient regardless of Rh status
  3. Type A with weak D antigen, treated as A-positive for donor purposes and A-negative for recipient purposes
  4. Type A with inconclusive Rh status, requiring repeat testing before any transfusion decisions
  5. Type A-positive with weak D variant, treated as A-positive for all transfusion purposes (correct answer)
Explanation: Blood typing questions require understanding both ABO and Rh antigen systems, plus the critical distinction between weak antigen expression and true negative results. When you encounter scenarios involving weak reactions, remember that patient safety always takes precedence over convenience. This sample shows clear A antigen presence (agglutination with anti-A) and absence of B antigen (no reaction with anti-B), making it Type A blood. The Rh status is more complex: no reaction with standard anti-Rh serum suggests Rh-negative, but weak agglutination with sensitive anti-D serum indicates a weak D variant. Weak D individuals have fewer D antigens on their red blood cells than typical Rh-positive people. For transfusion safety, weak D individuals are treated as Rh-positive when donating (since they can stimulate anti-D antibodies in Rh-negative recipients) but as Rh-negative when receiving blood (since they may lack some D antigen variants and could develop antibodies against stronger D antigens). Therefore, this blood should be classified as A-positive for donor purposes but A-negative for recipient purposes. Answer A incorrectly treats this as standard A-positive, ignoring the weak D complexity. Answer B incorrectly classifies this as A-negative, missing the positive anti-D reaction entirely. Answer D suggests inconclusive results, but the weak D pattern is actually a recognized, interpretable finding that doesn't require repeat testing. When studying blood banking, remember that weak antigen variants require special handling rules that prioritize preventing alloimmunization. The conservative approach—treating patients as the "safer" type for each situation—prevents serious transfusion reactions.

Question 3

A hospital blood bank receives an emergency request for type O-negative blood for a trauma patient. The blood bank has the following inventory: 15 units of O-negative, 8 units of O-positive, 12 units of A-negative, 6 units of A-positive, 4 units of B-negative, 3 units of B-positive, 2 units of AB-negative, and 1 unit of AB-positive. The trauma patient requires 8 units immediately, and their blood type is unknown.

Given the emergency situation described in the passage above, what is the primary reason why O-negative blood is the preferred choice for this patient?

  1. O-negative blood has the highest oxygen-carrying capacity among all blood types during trauma situations
  2. O-negative blood lacks both A and B antigens and Rh antigens, minimizing the risk of agglutination reactions (correct answer)
  3. O-negative blood contains universal antibodies that can neutralize any incompatible antigens in the patient
  4. O-negative blood has enhanced clotting factors that help control bleeding during trauma emergencies
  5. O-negative blood can be stored longer than other blood types, ensuring better availability during emergencies
Explanation: Blood typing questions in emergency medicine scenarios test your understanding of the ABO and Rh blood group systems and their role in transfusion compatibility. When you see a question about emergency blood transfusions with unknown patient blood type, think immediately about universal donor blood and antigen-antibody reactions. O-negative blood is called the "universal donor" because it lacks A antigens, B antigens, and Rh (D) antigens on the red blood cell surface. Since the patient's blood type is unknown and there's no time for cross-matching, O-negative blood minimizes the risk of a potentially fatal agglutination reaction. If the patient has antibodies against A, B, or Rh antigens in their plasma, these antibodies won't find their corresponding antigens on the O-negative donor cells, preventing clumping and hemolysis. Choice A is incorrect because oxygen-carrying capacity depends on hemoglobin concentration, not blood type. All blood types have similar oxygen transport capabilities. Choice C misunderstands blood compatibility—O-negative blood doesn't contain "universal antibodies" that neutralize antigens. In fact, O-negative individuals typically have anti-A and anti-B antibodies in their plasma, but donated red blood cells don't contain significant amounts of donor plasma. Choice D is wrong because clotting factors aren't determined by ABO or Rh blood groups, and O-negative blood doesn't have enhanced clotting properties. Remember: In emergency transfusion questions, focus on antigen presence or absence on donor red blood cells, not the donor's plasma antibodies or unrelated blood properties like clotting factors.

Question 4

A medical student is reviewing blood compatibility and notes that a type AB-positive patient can receive red blood cells from a type O-negative donor, but a type O-negative patient cannot receive red blood cells from a type AB-positive donor. Which principle best explains this directional incompatibility?

  1. AB-positive patients have stronger immune systems that can tolerate foreign antigens better than O-negative patients
  2. The presence of antibodies in the recipient's plasma determines compatibility, not the antigens on donor cells
  3. O-negative blood cells are smaller and can fit better into AB-positive circulation than vice versa
  4. AB-positive patients lack antibodies against A, B, and Rh antigens, while O-negative patients have anti-A and anti-B antibodies (correct answer)
  5. The Rh factor creates a one-way compatibility barrier that prevents reverse transfusions between these types
Explanation: When you encounter blood compatibility questions, focus on the key principle: compatibility depends on what antibodies the recipient has in their plasma, not what antigens the donor has on their cells. Let's work through the logic. Type AB-positive patients have A, B, and Rh antigens on their red blood cells, so their immune system recognizes these as "self." This means they don't produce antibodies against A, B, or Rh antigens—making them universal recipients for red blood cells. They can safely receive O-negative blood because they won't attack it. In contrast, type O-negative patients have no A, B, or Rh antigens on their cells, so their immune system treats these as foreign. They actively produce anti-A and anti-B antibodies, which would immediately attack AB-positive donor cells, causing a potentially fatal transfusion reaction. Answer D correctly captures this mechanism—AB-positive patients lack the antibodies that would attack donor cells, while O-negative patients have antibodies ready to attack foreign antigens. Answer A incorrectly suggests immune system strength determines compatibility rather than specific antibody presence. Answer B contains a contradiction—it correctly states that recipient antibodies determine compatibility, but this actually supports why the directional incompatibility exists, making it an incomplete explanation. Answer C proposes a fictional mechanism about cell size that has no basis in physiology. Remember this pattern: universal donors (O-negative) lack antigens that could be attacked, while universal recipients (AB-positive) lack antibodies that would do the attacking. The danger always comes from recipient antibodies attacking donor antigens.

Question 5

During blood typing, a donor's blood shows agglutination with anti-A serum and anti-Rh serum, but no agglutination with anti-B serum. However, when the donor's plasma is mixed with known type B red blood cells, no agglutination occurs. What is unusual about this donor's blood?

  1. The donor appears to be type A-positive but lacks the expected anti-B antibodies (correct answer)
  2. The donor has received a recent transfusion that altered their antibody levels
  3. The donor has an autoimmune condition affecting antibody production
  4. The donor shows evidence of a rare blood type variant
  5. The donor's sample was contaminated during collection
Explanation: When analyzing blood typing results, you need to consider both the antigens present on red blood cells (determined by agglutination with antisera) and the antibodies naturally present in plasma. Normally, people develop antibodies against ABO antigens they don't possess. This donor's results show a clear pattern: agglutination with anti-A and anti-Rh sera indicates A-positive blood type, while no agglutination with anti-B serum confirms absence of B antigens. However, the key finding is that the donor's plasma doesn't agglutinate known type B cells, meaning anti-B antibodies are missing. Typically, type A individuals naturally produce anti-B antibodies, so their absence is unusual. Answer A correctly identifies this inconsistency - the donor appears A-positive but lacks expected anti-B antibodies. This could occur due to immunodeficiency, certain medications, or other medical conditions affecting antibody production. Answer B suggests recent transfusion, but transfused antibodies would be diluted and temporary, not completely absent. Answer C mentions autoimmune conditions, but these typically involve abnormal antibody production rather than complete absence of specific natural antibodies. Answer D proposes a rare blood variant, but the ABO and Rh typing results are straightforward - the unusual finding is the missing antibody, not the antigens. Remember that blood typing isn't just about identifying antigens on cells - always consider the corresponding antibodies that should be present in plasma. Discrepancies between expected and observed antibody patterns often indicate underlying medical conditions or immune system issues.

Question 6

A pregnant woman with type A-negative blood has a partner with type B-positive blood. Their first child was type AB-positive. If they have a second child, what is the probability that this child will have a blood type that could cause hemolytic disease of the newborn (HDN) due to maternal antibodies?

  1. 0% because the mother's first pregnancy was uncomplicated
  2. 25% because only specific genetic combinations result in HDN risk
  3. 50% because any Rh-positive child could trigger HDN in subsequent pregnancies (correct answer)
  4. 75% because multiple blood group incompatibilities increase the risk substantially
  5. 100% because the mother will definitely have antibodies from her first pregnancy
Explanation: When you encounter blood type genetics questions involving pregnancy, focus on both ABO compatibility and Rh factor inheritance, as both can cause maternal-fetal blood incompatibilities. Let's analyze the genetics here. The mother (A-negative) can contribute either A or O alleles, plus she's Rh-negative (rr). The father (B-positive) can contribute B or O alleles and is likely Rh-positive (Rr, since their first child is Rh-positive but he could also be RR). Since their first child is AB-positive, we know the father contributed B and Rh-positive alleles. The key insight is that during the first pregnancy with an Rh-positive baby, the Rh-negative mother likely became sensitized to the Rh antigen, producing anti-Rh antibodies. For any future pregnancy, if the baby is Rh-positive, these maternal antibodies can cross the placenta and attack the baby's red blood cells, causing hemolytic disease of the newborn. Looking at the second pregnancy: the probability of an Rh-positive child depends on the father's genotype. If he's Rr (most likely), there's a 50% chance each child will be Rh-positive. Answer choice A is wrong because sensitization from the first pregnancy creates future risk. Choice B incorrectly focuses on complex genetic combinations when Rh incompatibility alone is sufficient. Choice D overstates the risk percentage and misunderstands the mechanism. The correct answer is C: 50% probability that any Rh-positive child will be at risk for HDN due to the mother's existing anti-Rh antibodies. Study tip: Remember that Rh sensitization typically occurs during or after the first Rh-incompatible pregnancy, creating risk for subsequent Rh-positive babies.

Question 7

A patient with type B-negative blood has been receiving multiple transfusions over several months. Recent cross-matching shows unexpected agglutination with some type B-negative donor units that should be compatible. The patient's antibody screen is positive for anti-E antibodies. What is the most likely explanation for this incompatibility?

  1. The patient has developed anti-B antibodies due to repeated transfusions of B-positive blood
  2. The donor blood contains E antigens from the Rh system, causing incompatibility beyond standard ABO/Rh testing (correct answer)
  3. The patient has been mistyped and is actually type O-negative, explaining the anti-B reaction
  4. Cross-contamination occurred during testing, causing false positive agglutination reactions
  5. The patient has developed autoantibodies that react with their own B antigens
Explanation: When you encounter blood compatibility issues despite apparent ABO/Rh matching, think beyond the basic blood typing system. The human blood contains over 300 known antigens across multiple blood group systems, and the Rh system alone includes more than just the D antigen we commonly test for. The correct answer is B because this patient has developed anti-E antibodies, which are part of the extended Rh system (C, c, D, E, e antigens). When patients receive multiple transfusions, they can become sensitized to minor antigens they lack but that are present in donor blood. The E antigen is fairly common, so some B-negative donor units will carry it while others won't. Only the E-positive units would cause agglutination in this now-sensitized patient, explaining why some "compatible" B-negative units react while others don't. Answer A is wrong because anti-B antibodies would cause reactions with all type B blood, not just some units. Answer C is incorrect because an O-negative patient would react with all B-positive blood from the start, not develop reactions after months of transfusions. Answer D doesn't explain the specific anti-E antibody finding or why only certain B-negative units react. For anatomy and physiology exams, remember that blood compatibility extends far beyond ABO/Rh basics. Multiple transfusions can sensitize patients to minor antigens, requiring extended phenotyping and crossmatching. Focus on understanding how the immune system responds to foreign antigens over time.

Question 8

In a genetics lab, students are analyzing the possible blood types of offspring from two parents. The father has genotype IAIBI^A I^B and is Rh-positive (Dd), while the mother has genotype IBIBI^B I^B and is Rh-negative (dd). What percentage of their offspring would be expected to have type AB blood that is Rh-negative?

  1. 0% because both parents have B antigens, preventing AB offspring
  2. 25% because half will be AB and half of those will be Rh-negative (correct answer)
  3. 50% because the father can contribute either A or B alleles
  4. 75% because most offspring inherit both parental ABO alleles
  5. 100% because the father's genotype guarantees AB offspring
Explanation: When you encounter genetics problems involving multiple traits, you need to analyze each trait separately using Punnett squares, then combine the probabilities. For the ABO blood type cross between father (IAIBI^A I^B) and mother (IBIBI^B I^B), the father can contribute either IAI^A or IBI^B alleles, while the mother can only contribute IBI^B alleles. This gives offspring genotypes of IAIBI^A I^B (type AB) and IBIBI^B I^B (type B) in a 1:1 ratio, so 50% will have type AB blood. For the Rh factor cross between father (Dd) and mother (dd), the father contributes either D or d, while the mother only contributes d. This produces Dd (Rh-positive) and dd (Rh-negative) offspring in a 1:1 ratio, so 50% will be Rh-negative. To find offspring that are both type AB and Rh-negative, multiply these independent probabilities: 50% × 50% = 25%. Option A is incorrect because having B antigens doesn't prevent AB offspring—the father's IAI^A allele combined with the mother's IBI^B creates AB blood type. Option C confuses the probability of being AB (50%) with the final answer, forgetting to account for the Rh factor. Option D misunderstands basic genetics—offspring don't inherit "most" alleles; they inherit exactly one allele per gene from each parent. Remember: for multi-trait genetics problems, solve each trait independently, then multiply the probabilities. This approach works for any number of unlinked traits.

Question 9

During blood typing, a patient's blood shows agglutination with anti-A serum and anti-Rh serum, but no agglutination with anti-B serum. When this patient's serum is mixed with type B red blood cells, agglutination occurs. What is this patient's complete blood type?

  1. Type A-positive with anti-B antibodies present in serum (correct answer)
  2. Type AB-positive with no naturally occurring antibodies in serum
  3. Type A-negative with anti-A antibodies present in serum
  4. Type B-positive with anti-A antibodies present in serum
  5. Type O-positive with both anti-A and anti-B antibodies in serum
Explanation: When you encounter blood typing questions, you need to interpret both the agglutination patterns with antisera and the serum compatibility tests to determine the complete ABO-Rh type and antibody profile. Let's work through this systematically. The patient's blood agglutinates with anti-A serum (indicating A antigens present) and anti-Rh serum (indicating Rh-positive), but shows no reaction with anti-B serum (no B antigens). This makes the patient type A-positive. When the patient's serum is mixed with type B red blood cells and agglutination occurs, this confirms that anti-B antibodies are present in the patient's serum—which is exactly what we expect in type A blood. Now let's examine why the other options fail. Option B suggests AB-positive blood, but this contradicts the lack of agglutination with anti-B serum—AB blood would react with both anti-A and anti-B. Option C proposes A-negative, but the blood clearly agglutinated with anti-Rh serum, confirming Rh-positive status. Additionally, anti-A antibodies in an A-type person's serum would cause autoimmune reactions. Option D suggests B-positive blood, but this directly contradicts the agglutination with anti-A serum and lack of reaction with anti-B serum. Remember that people naturally produce antibodies against the ABO antigens they lack. Type A individuals have anti-B antibodies, type B have anti-A antibodies, type AB have neither, and type O have both. Always match the antigen presence (determined by agglutination with antisera) with the expected antibody pattern (confirmed by serum testing).

Question 10

A patient with type O blood requires an emergency transfusion, but only type A blood is available. The attending physician decides to proceed with a small volume transfusion of packed red blood cells. What is the most likely immediate consequence?

  1. The patient's plasma will agglutinate the donor red blood cells due to anti-A antibodies (correct answer)
  2. The donor plasma will agglutinate the patient's red blood cells due to anti-O antibodies
  3. Cross-matching will prevent any adverse reaction since both are Rh-positive
  4. The transfusion will be successful because O is the universal recipient
  5. Hemolysis will occur due to ABO compatibility but Rh incompatibility
Explanation: When you encounter blood transfusion questions, focus on the ABO blood group system and the antibodies each blood type naturally produces. Type O individuals have anti-A and anti-B antibodies in their plasma, while type A individuals have anti-B antibodies. In this scenario, the type O patient has anti-A antibodies circulating in their plasma. When type A packed red blood cells (which have A antigens on their surface) are transfused, the patient's anti-A antibodies will immediately bind to these foreign A antigens, causing agglutination (clumping) of the donor cells. This creates a potentially life-threatening hemolytic transfusion reaction. Looking at the wrong answers: Option B incorrectly suggests that donor plasma contains "anti-O antibodies" - but there's no such thing as anti-O antibodies since O represents the absence of A or B antigens. Option C mentions cross-matching and Rh status, but cross-matching would actually reveal this ABO incompatibility and prevent the transfusion, and Rh compatibility doesn't override ABO incompatibility. Option D contains a critical misconception - type O individuals are universal donors, not recipients, because they lack A and B antigens that could react with recipient antibodies. The correct answer is A because the patient's existing anti-A antibodies will attack the incoming type A red blood cells. Remember this key principle: Type O individuals are universal donors but have the most restrictive receiving requirements since they possess both anti-A and anti-B antibodies. Always match the patient's antibodies against the donor's antigens to predict transfusion reactions.

Question 11

In a laboratory error, blood samples from four patients were mixed before typing could be completed. The mixed sample shows agglutination with anti-A, anti-B, and anti-Rh sera. Based on this pattern, which combination of original blood types would be impossible to have contributed to this mixed sample?

  1. Type O Rh-positive, type A Rh-negative, type B Rh-positive, and type AB Rh-negative
  2. Type A Rh-positive, type B Rh-positive, type AB Rh-negative, and type O Rh-negative
  3. Type AB Rh-positive, type O Rh-negative, type A Rh-positive, and type B Rh-negative
  4. Type A Rh-negative, type B Rh-negative, type O Rh-negative, and type AB Rh-negative (correct answer)
Explanation: For the mixed sample to show agglutination with anti-Rh serum, at least one of the original samples must have been Rh-positive. Choice D contains only Rh-negative blood types, making it impossible to produce agglutination with anti-Rh serum. All other combinations include at least one Rh-positive sample. The agglutination with anti-A and anti-B sera would occur as long as the mixture contains blood with A antigens (from type A or AB blood) and B antigens (from type B or AB blood), which all the other choices provide.

Question 12

A pregnant woman with type O Rh-negative blood has developed anti-D antibodies from a previous pregnancy. Her current fetus has been determined to be type A Rh-positive. Which of the following best explains the primary immunological concern and its underlying mechanism?

  1. ABO incompatibility will cause immediate hemolytic disease because maternal anti-A antibodies are primarily IgG and cross the placenta readily
  2. Rh incompatibility poses the greatest risk because existing maternal anti-D antibodies are IgG and will target fetal Rh-positive cells (correct answer)
  3. Both ABO and Rh incompatibilities are equally concerning since the mother will produce new antibodies against both A and D antigens
  4. Neither incompatibility is concerning because maternal antibodies cannot cross the placental barrier during the second trimester
Explanation: The primary concern is Rh incompatibility because the mother already has anti-D antibodies (IgG) from previous sensitization, which readily cross the placenta and attack fetal Rh-positive red blood cells, causing hemolytic disease of the newborn. ABO incompatibility is typically less severe because maternal anti-A antibodies are primarily IgM (which don't cross the placenta easily), and fetal A antigens are not fully developed. Choice A is wrong because maternal anti-A antibodies are mainly IgM. Choice C is wrong because ABO incompatibility is generally milder, and the Rh sensitization already occurred. Choice D is wrong because IgG antibodies do cross the placenta.

Question 13

A blood bank technician observes that a type B Rh-negative patient's plasma causes agglutination when mixed with type A Rh-positive red blood cells, but shows no reaction with type B Rh-positive cells or type O Rh-negative cells. However, when mixed with type AB Rh-negative cells, weak agglutination occurs. What antibodies are most likely present in this patient's plasma?

  1. Anti-A antibodies only, with the weak reaction due to low antibody concentration against the A antigen (correct answer)
  2. Anti-A and anti-D antibodies, with the AB reaction showing both antibody types are present
  3. Anti-A, anti-B, and anti-D antibodies, indicating an unusual immune response pattern
  4. Anti-A antibodies and an additional antibody against a minor blood group antigen present on AB cells
Explanation: Type B Rh-negative individuals naturally produce anti-A antibodies. The strong agglutination with type A Rh-positive cells confirms anti-A presence. No reaction with type B or type O cells is expected (no A antigen present). The weak agglutination with type AB Rh-negative cells occurs because these cells have A antigens, but the reaction may be weaker due to antigen density differences or competing B antigens. Choice B is wrong because there's no reaction with Rh-positive cells of compatible ABO type. Choice C is wrong because there's no evidence of anti-B (no reaction with B cells) or anti-D. Choice D unnecessarily invokes rare antibodies when anti-A explains all observations.

Question 14

A genetics counselor is explaining inheritance patterns to a couple where one parent has type AB blood and the other has type O blood. If they have four children, what is the most accurate prediction about the possible blood type distribution among their offspring?

  1. All children will have either type A or type B blood, with equal probability of each type occurring (correct answer)
  2. Two children will have type A blood, one will have type B blood, and one will have type AB blood
  3. Each child has a 25% chance of type A, 25% chance of type B, 25% chance of type AB, and 25% chance of type O
  4. All children will have type AB blood since this is the dominant genotype from the AB parent
Explanation: The AB parent (genotype IAIB) can contribute either IA or IB alleles. The type O parent (genotype ii) can only contribute i alleles. Therefore, offspring can only be IAi (type A) or IBi (type B), each with 50% probability. With four children, the expected outcome is equal chances of type A or B for each child. Choice B incorrectly applies a fixed ratio to a specific number of children rather than probability per child. Choice C incorrectly includes impossible outcomes (AB and O cannot occur from this cross). Choice D is wrong because AB is not dominant and this cross cannot produce AB offspring.

Question 15

A patient presents with a history of multiple blood transfusions and now shows positive reactions during antibody screening tests. The patient's blood type is O Rh-positive, but their serum agglutinates with red blood cells from several different O Rh-positive donors. What is the most likely cause of this incompatibility pattern?

  1. The patient has developed autoantibodies against their own red blood cell antigens due to transfusion reactions
  2. Multiple transfusions have caused the patient to develop antibodies against minor blood group antigens (Kell, Duffy, Kidd systems) (correct answer)
  3. The patient's ABO typing was incorrect, and they actually have type A or B blood with naturally occurring antibodies
  4. Repeated transfusions have altered the patient's blood type from O to a mixed phenotype causing self-incompatibility
Explanation: Multiple transfusions can sensitize patients to minor blood group antigens (such as Kell, Duffy, Kidd, or other systems) that are not routinely tested in basic ABO/Rh typing. These antibodies can cause incompatibility with donors who have those antigens, even if ABO/Rh types match. Choice A describes autoantibodies, which would react with the patient's own cells, not just donor cells. Choice C is unlikely given the clinical history and wouldn't explain reactions with multiple O donors. Choice D is impossible because transfusions don't change the recipient's blood type permanently.

Question 16

In an emergency department, a patient requires immediate blood transfusion before complete typing can be performed. Initial rapid testing shows the patient is Rh-positive, but ABO typing is inconclusive due to weak reactions. The blood bank has type O Rh-positive blood immediately available. What additional consideration should guide the transfusion decision beyond basic ABO/Rh compatibility?

  1. Type O blood can be safely given regardless of the patient's actual ABO type, so immediate transfusion is appropriate without further testing
  2. The weak ABO reactions suggest possible antibodies against high-frequency antigens, requiring extended phenotyping before any transfusion
  3. Type O Rh-positive blood should be given, but the patient should be monitored for signs of minor blood group incompatibilities during transfusion (correct answer)
  4. The inconclusive ABO typing indicates possible ABO subgroups, making type O blood potentially incompatible due to unexpected antibodies
Explanation: While type O Rh-positive blood is compatible with any ABO type for emergency use, patients with transfusion history or certain medical conditions may have developed antibodies to minor blood group systems that cannot be detected in rapid testing. Monitoring during transfusion allows for detection of unexpected reactions while not delaying critical care. Choice A is overly simplistic and ignores potential minor group incompatibilities. Choice B would dangerously delay emergency treatment. Choice D incorrectly suggests O blood could be incompatible due to ABO subgroups (O blood lacks A and B antigens regardless of subgroup issues).

Question 17

During a cross-match procedure, a patient's serum is tested against donor red blood cells. The major cross-match shows no agglutination, but the minor cross-match shows strong agglutination. Additionally, the patient's blood type is A Rh-positive, and the donor blood type is O Rh-positive. What is the most likely explanation for these results?

  1. The patient has developed unexpected anti-O antibodies, making the transfusion incompatible despite normal ABO typing
  2. The donor has unusually high levels of anti-A antibodies, creating incompatibility in the minor cross-match (correct answer)
  3. There is a technical error in the cross-match procedure, as these blood types should be fully compatible
  4. The patient has antibodies against a non-ABO blood group antigen present on the donor's red blood cells
Explanation: In cross-matching, the major cross-match tests patient serum against donor cells (checking for patient antibodies against donor antigens), while the minor cross-match tests donor serum against patient cells (checking for donor antibodies against patient antigens). Type O donors have anti-A and anti-B antibodies. If the donor has particularly high levels of anti-A antibodies, they could agglutinate the patient's A-positive cells in the minor cross-match. Choice A is wrong because anti-O antibodies don't exist (O has no antigens). Choice C is wrong because minor cross-match incompatibility can occur with high-titer donor antibodies. Choice D would cause major cross-match agglutination, not minor.